Table 5.
Frequencies of allelic version of genes KIR3DL1/3DS1 and KIR2DL2/2DL3 in HIV-positive and HIV-negative people
| Groups | 3DL1 | 3DL1/3DS1 | 3DS1 | 2DL2 a | 2DL2/2DL3 a | 2DL3 a | |
|---|---|---|---|---|---|---|---|
| BD, n = 98 | n | 64 | 30 | 4 | 7 | 39 | 52 |
| % | 65.31 | 30.61 | 4.08 | 7.14 | 39.80 | 53.06 | |
| EU, n = 118 | n | 81 | 34 | 3 | 4 | 49 | 64 |
| % | 68.65 | 28.81 | 2.54 | 3.39 | 41.52 | 54.24 | |
| HIV+, n = 459 | n | 287 | 150 | 22 | 61 | 196 | 189 |
| % | 62.53 | 32.68 | 4.79 | 13.29 | 42.70 | 41.18 | |
| OR | 0.76 | 1.20 | 1.93 | 4.37 | 1.05 | 0.59 | |
| CI 95 % | 0.49 | 0.77 | 0.57 | 1.56 | 0.70 | 0.39 | |
| 1.17 | 1.87 | 6.56 | 12.27 | 1.58 | 0.89 | ||
| p | 0.436 | 0.844 | 0.569 | 0.005 | 1.636 | 0.022 | |
p Value after Bonferroni correction
BD - blood donors from Lower Silesia region of Poland, EU - exposed, HIV-1-seronegative, HIV+ exposed to HIV and seropositive, OR - odds ratio, based on the comparison of EU and HIV, CI 95 % - 95 % confidence interval
aOne of EU individuals (0.85 %) and 13 HIV+ individuals (2.83 %) had neither 2DL2 nor 2DL3